HEADER SIGNALING PROTEIN 02-JAN-14 4O9R TITLE HUMAN SMOOTHENED RECEPTOR STRUCTURE IN COMPLEX WITH CYCLOPAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SMOOTHENED HOMOLOG/SOLUBLE CYTOCHROME B562 CHIMERIC COMPND 3 PROTEIN; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: UNP Q99835 RESIDUES 190-433, P0ABE7 RESIDUES 23-128, Q99835 COMPND 6 RESIDUES 441-555; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 9606, 562; SOURCE 4 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PFASTBAC KEYWDS SERIAL FEMTOSECOND CRYSTALLOGRAPHY, HUMAN SMO RECEPTOR, CYCLOPAMINE, KEYWDS 2 NOVEL PROTEIN ENGINEERING, GPCR NETWORK, PSI-BIOLOGY, FREE ELECTRON KEYWDS 3 LASER, STRUCTURAL GENOMICS, MEMBRANE PROTEIN, XFEL, LCP, ROOM KEYWDS 4 TEMPERATURE STRUCTURE, GPCR, MEMBRANE, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR C.WANG,U.WEIERSTALL,D.JAMES,T.A.WHITE,D.WANG,W.LIU,J.C.H.SPENCE, AUTHOR 2 R.B.DOAK,G.NELSON,P.FROMME,R.FROMME,I.GROTJOHANN,C.KUPITZ, AUTHOR 3 N.A.ZATSEPIN,H.LIU,S.BASU,D.WACKER,G.W.HAN,V.KATRITCH,S.BOUTET, AUTHOR 4 M.MESSERSCHMIDT,G.J.WILLAMS,J.E.KOGLIN,M.M.SEIBERT,M.KLINKER,C.GATI, AUTHOR 5 R.L.SHOEMAN,A.BARTY,H.N.CHAPMAN,R.A.KIRIAN,K.R.BEYERLEIN, AUTHOR 6 R.C.STEVENS,D.LI,S.T.A.SHAH,N.HOWE,M.CAFFREY,V.CHEREZOV,GPCR NETWORK AUTHOR 7 (GPCR) REVDAT 6 16-OCT-24 4O9R 1 REMARK REVDAT 5 20-SEP-23 4O9R 1 REMARK REVDAT 4 16-AUG-23 4O9R 1 REMARK SEQADV REVDAT 3 14-FEB-18 4O9R 1 REMARK REVDAT 2 02-AUG-17 4O9R 1 SOURCE REMARK REVDAT 1 05-MAR-14 4O9R 0 JRNL AUTH U.WEIERSTALL,D.JAMES,C.WANG,T.A.WHITE,D.WANG,W.LIU, JRNL AUTH 2 J.C.SPENCE,R.BRUCE DOAK,G.NELSON,P.FROMME,R.FROMME, JRNL AUTH 3 I.GROTJOHANN,C.KUPITZ,N.A.ZATSEPIN,H.LIU,S.BASU,D.WACKER, JRNL AUTH 4 G.W.HAN,V.KATRITCH,S.BOUTET,M.MESSERSCHMIDT,G.J.WILLIAMS, JRNL AUTH 5 J.E.KOGLIN,M.MARVIN SEIBERT,M.KLINKER,C.GATI,R.L.SHOEMAN, JRNL AUTH 6 A.BARTY,H.N.CHAPMAN,R.A.KIRIAN,K.R.BEYERLEIN,R.C.STEVENS, JRNL AUTH 7 D.LI,S.T.SHAH,N.HOWE,M.CAFFREY,V.CHEREZOV JRNL TITL LIPIDIC CUBIC PHASE INJECTOR FACILITATES MEMBRANE PROTEIN JRNL TITL 2 SERIAL FEMTOSECOND CRYSTALLOGRAPHY. JRNL REF NAT COMMUN V. 5 3309 2014 JRNL REFN ESSN 2041-1723 JRNL PMID 24525480 JRNL DOI 10.1038/NCOMMS4309 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.4_1496) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.33 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 75.4 REMARK 3 NUMBER OF REFLECTIONS : 8082 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.234 REMARK 3 R VALUE (WORKING SET) : 0.232 REMARK 3 FREE R VALUE : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.940 REMARK 3 FREE R VALUE TEST SET COUNT : 399 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.3279 - 4.6195 1.00 3413 184 0.2030 0.2413 REMARK 3 2 4.6195 - 3.6675 0.93 3133 152 0.2582 0.3240 REMARK 3 3 3.6675 - 3.2041 0.33 1137 63 0.3490 0.4084 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.500 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.770 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 3513 REMARK 3 ANGLE : 0.613 4807 REMARK 3 CHIRALITY : 0.024 553 REMARK 3 PLANARITY : 0.003 603 REMARK 3 DIHEDRAL : 11.927 1183 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4O9R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JAN-14. REMARK 100 THE DEPOSITION ID IS D_1000084220. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : MAR-13 REMARK 200 TEMPERATURE (KELVIN) : 294 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : FREE ELECTRON LASER REMARK 200 BEAMLINE : CXI REMARK 200 X-RAY GENERATOR MODEL : SLAC LCLS BEAMLINE CXI REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.3 REMARK 200 MONOCHROMATOR : K-B MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : CORNELL-SLAC PIXEL ARRAY REMARK 200 DETECTOR (CSPAD) REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTFEL REMARK 200 DATA SCALING SOFTWARE : CRYSTFEL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10785 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4JKV FOR SMO AND PDB ENTRY 4IB4 FOR BRIL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM HEPES, 30 % (V/V) PEG 400, 100 REMARK 280 MM NACL , PH 7.0, LIPIDIC CUBIC PHASE (LCP), TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 78.65000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 187 REMARK 465 GLY A 188 REMARK 465 THR A 189 REMARK 465 SER A 190 REMARK 465 GLY A 191 REMARK 465 ALA A 345 REMARK 465 LEU A 346 REMARK 465 GLY A 347 REMARK 465 THR A 348 REMARK 465 THR A 349 REMARK 465 TYR A 350 REMARK 465 GLN A 351 REMARK 465 PRO A 352 REMARK 465 LEU A 353 REMARK 465 SER A 354 REMARK 465 GLY A 497 REMARK 465 LEU A 498 REMARK 465 PRO A 499 REMARK 465 THR A 500 REMARK 465 LYS A 501 REMARK 465 GLN A 502 REMARK 465 PRO A 503 REMARK 465 ILE A 504 REMARK 465 LEU A 552 REMARK 465 THR A 553 REMARK 465 GLY A 554 REMARK 465 GLN A 555 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 261 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 291 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 344 CG CD CE NZ REMARK 470 LYS A 356 CG CD CE NZ REMARK 470 LYS A 430 CG CD CE NZ REMARK 470 LYS A1019 CD CE NZ REMARK 470 LYS A1027 CG CD CE NZ REMARK 470 LYS A1042 CG CD CE NZ REMARK 470 LYS A1047 CG CD CE NZ REMARK 470 ASP A1050 CG OD1 OD2 REMARK 470 ASP A1054 CG OD1 OD2 REMARK 470 LYS A1059 CG CD CE NZ REMARK 470 LYS A1077 CG CD CE NZ REMARK 470 LYS A1083 CG CD CE NZ REMARK 470 LYS A1085 CG CD CE NZ REMARK 470 LYS A 444 CG CD CE NZ REMARK 470 ASN A 446 CG OD1 ND2 REMARK 470 ARG A 485 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 491 CG CD OE1 NE2 REMARK 470 ILE A 496 CG1 CG2 CD1 REMARK 470 LYS A 510 CG CD CE NZ REMARK 470 LYS A 539 CG CD CE NZ REMARK 470 ARG A 546 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 547 CG CD NE CZ NH1 NH2 REMARK 470 TRP A 549 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 549 CZ3 CH2 REMARK 470 ARG A 551 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 208 -97.15 54.21 REMARK 500 ALA A 236 -72.88 -69.77 REMARK 500 ASP A 255 40.33 -151.84 REMARK 500 SER A 259 17.07 -141.08 REMARK 500 ASP A 287 109.80 -54.14 REMARK 500 ASP A 298 30.67 -94.70 REMARK 500 ALA A 379 71.27 56.05 REMARK 500 VAL A 404 -58.80 -129.65 REMARK 500 ILE A1102 -54.69 -125.49 REMARK 500 ALA A 441 -159.88 58.60 REMARK 500 ALA A 442 89.27 64.04 REMARK 500 SER A 443 117.61 -171.17 REMARK 500 ASN A 446 138.00 75.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CY8 A 1201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: GPCR-131 RELATED DB: TARGETTRACK DBREF 4O9R A 190 433 UNP Q99835 SMO_HUMAN 190 433 DBREF 4O9R A 1001 1106 UNP P0ABE7 C562_ECOLX 23 128 DBREF 4O9R A 441 555 UNP Q99835 SMO_HUMAN 441 555 SEQADV 4O9R GLY A 187 UNP Q99835 EXPRESSION TAG SEQADV 4O9R GLY A 188 UNP Q99835 EXPRESSION TAG SEQADV 4O9R THR A 189 UNP Q99835 EXPRESSION TAG SEQADV 4O9R TRP A 1007 UNP P0ABE7 MET 29 ENGINEERED MUTATION SEQADV 4O9R ILE A 1102 UNP P0ABE7 HIS 124 ENGINEERED MUTATION SEQADV 4O9R LEU A 1106 UNP P0ABE7 ARG 128 ENGINEERED MUTATION SEQRES 1 A 468 GLY GLY THR SER GLY GLN CYS GLU VAL PRO LEU VAL ARG SEQRES 2 A 468 THR ASP ASN PRO LYS SER TRP TYR GLU ASP VAL GLU GLY SEQRES 3 A 468 CYS GLY ILE GLN CYS GLN ASN PRO LEU PHE THR GLU ALA SEQRES 4 A 468 GLU HIS GLN ASP MET HIS SER TYR ILE ALA ALA PHE GLY SEQRES 5 A 468 ALA VAL THR GLY LEU CYS THR LEU PHE THR LEU ALA THR SEQRES 6 A 468 PHE VAL ALA ASP TRP ARG ASN SER ASN ARG TYR PRO ALA SEQRES 7 A 468 VAL ILE LEU PHE TYR VAL ASN ALA CYS PHE PHE VAL GLY SEQRES 8 A 468 SER ILE GLY TRP LEU ALA GLN PHE MET ASP GLY ALA ARG SEQRES 9 A 468 ARG GLU ILE VAL CYS ARG ALA ASP GLY THR MET ARG LEU SEQRES 10 A 468 GLY GLU PRO THR SER ASN GLU THR LEU SER CYS VAL ILE SEQRES 11 A 468 ILE PHE VAL ILE VAL TYR TYR ALA LEU MET ALA GLY VAL SEQRES 12 A 468 VAL TRP PHE VAL VAL LEU THR TYR ALA TRP HIS THR SER SEQRES 13 A 468 PHE LYS ALA LEU GLY THR THR TYR GLN PRO LEU SER GLY SEQRES 14 A 468 LYS THR SER TYR PHE HIS LEU LEU THR TRP SER LEU PRO SEQRES 15 A 468 PHE VAL LEU THR VAL ALA ILE LEU ALA VAL ALA GLN VAL SEQRES 16 A 468 ASP GLY ASP SER VAL SER GLY ILE CYS PHE VAL GLY TYR SEQRES 17 A 468 LYS ASN TYR ARG TYR ARG ALA GLY PHE VAL LEU ALA PRO SEQRES 18 A 468 ILE GLY LEU VAL LEU ILE VAL GLY GLY TYR PHE LEU ILE SEQRES 19 A 468 ARG GLY VAL MET THR LEU PHE SER ILE LYS SER ASN HIS SEQRES 20 A 468 ALA ASP LEU GLU ASP ASN TRP GLU THR LEU ASN ASP ASN SEQRES 21 A 468 LEU LYS VAL ILE GLU LYS ALA ASP ASN ALA ALA GLN VAL SEQRES 22 A 468 LYS ASP ALA LEU THR LYS MET ARG ALA ALA ALA LEU ASP SEQRES 23 A 468 ALA GLN LYS ALA THR PRO PRO LYS LEU GLU ASP LYS SER SEQRES 24 A 468 PRO ASP SER PRO GLU MET LYS ASP PHE ARG HIS GLY PHE SEQRES 25 A 468 ASP ILE LEU VAL GLY GLN ILE ASP ASP ALA LEU LYS LEU SEQRES 26 A 468 ALA ASN GLU GLY LYS VAL LYS GLU ALA GLN ALA ALA ALA SEQRES 27 A 468 GLU GLN LEU LYS THR THR ARG ASN ALA TYR ILE GLN LYS SEQRES 28 A 468 TYR LEU ALA ALA SER LYS ILE ASN GLU THR MET LEU ARG SEQRES 29 A 468 LEU GLY ILE PHE GLY PHE LEU ALA PHE GLY PHE VAL LEU SEQRES 30 A 468 ILE THR PHE SER CYS HIS PHE TYR ASP PHE PHE ASN GLN SEQRES 31 A 468 ALA GLU TRP GLU ARG SER PHE ARG ASP TYR VAL LEU CYS SEQRES 32 A 468 GLN ALA ASN VAL THR ILE GLY LEU PRO THR LYS GLN PRO SEQRES 33 A 468 ILE PRO ASP CYS GLU ILE LYS ASN ARG PRO SER LEU LEU SEQRES 34 A 468 VAL GLU LYS ILE ASN LEU PHE ALA MET PHE GLY THR GLY SEQRES 35 A 468 ILE ALA MET SER THR TRP VAL TRP THR LYS ALA THR LEU SEQRES 36 A 468 LEU ILE TRP ARG ARG THR TRP CYS ARG LEU THR GLY GLN HET CY8 A1201 30 HETNAM CY8 CYCLOPAMINE HETSYN CY8 (3ALPHA,8ALPHA,14BETA,22S,23R)-17,23-EPOXYVERATRAMAN-3- HETSYN 2 CY8 OL FORMUL 2 CY8 C27 H41 N O2 HELIX 1 1 ASN A 202 TRP A 206 5 5 HELIX 2 2 THR A 223 VAL A 253 1 31 HELIX 3 3 ASP A 255 SER A 259 5 5 HELIX 4 4 PRO A 263 ALA A 283 1 21 HELIX 5 5 GLN A 284 MET A 286 5 3 HELIX 6 6 GLY A 288 CYS A 295 1 8 HELIX 7 7 LEU A 312 THR A 341 1 30 HELIX 8 8 PHE A 360 ALA A 379 1 20 HELIX 9 9 ASN A 396 VAL A 404 1 9 HELIX 10 10 VAL A 404 ALA A 1020 1 50 HELIX 11 11 ASN A 1022 LYS A 1042 1 21 HELIX 12 12 PRO A 1045 GLU A 1049 5 5 HELIX 13 13 SER A 1055 ASN A 1080 1 26 HELIX 14 14 LYS A 1083 ILE A 1102 1 20 HELIX 15 15 ASN A 446 ASN A 476 1 31 HELIX 16 16 ASN A 476 ASN A 493 1 18 HELIX 17 17 SER A 514 SER A 533 1 20 HELIX 18 18 THR A 534 TRP A 537 5 4 HELIX 19 19 ALA A 540 TRP A 549 1 10 SHEET 1 A 2 LEU A 197 ARG A 199 0 SHEET 2 A 2 CYS A 213 ILE A 215 -1 O GLY A 214 N VAL A 198 SHEET 1 B 2 VAL A 381 ASP A 384 0 SHEET 2 B 2 ILE A 389 VAL A 392 -1 O PHE A 391 N ASP A 382 SSBOND 1 CYS A 193 CYS A 213 1555 1555 2.03 SSBOND 2 CYS A 217 CYS A 295 1555 1555 2.03 SSBOND 3 CYS A 314 CYS A 390 1555 1555 2.03 SSBOND 4 CYS A 490 CYS A 507 1555 1555 2.04 CISPEP 1 VAL A 195 PRO A 196 0 2.44 CISPEP 2 TYR A 262 PRO A 263 0 -2.44 CISPEP 3 GLU A 305 PRO A 306 0 1.44 SITE 1 AC1 11 ASN A 219 PHE A 222 LEU A 303 ASP A 384 SITE 2 AC1 11 VAL A 386 TYR A 394 ARG A 400 ASP A 473 SITE 3 AC1 11 GLN A 477 PHE A 484 GLU A 518 CRYST1 40.500 157.300 52.400 90.00 97.00 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024691 0.000000 0.003032 0.00000 SCALE2 0.000000 0.006357 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019227 0.00000